Background: To determine the crude and age-adjusted point prevalence of motor neuron disease (MND) and its phenotypes (classical amyotrophic lateral sclerosis [ALS], primary lateral sclerosis [PLS] and progressive muscular atrophy [PMA]) using a comprehensive multi-source case ascertainment strategy. Methods: Cross-sectional population-based study with a prevalence date of 1 January 2025. Cases were identified through five complementary regional data sources and confirmed by clinical review against the revised El Escorial and Gold Coast criteria.
Prevalence of motor neuron disease and its clinical subtypes in the Valencian Community, Spain: a population-based cross-sectional study using linked electronic health records
calendar_today
October 9, 2026
person
Ros-Arlanzon, P., Vazquez-Costa, J. F., Merchan-Cabanillas, A., Vilar-Ventura, R., Pareja, A., Lorente-Gomez, L., Ronda-Perez, E., Diaz-Marin, C.
domain
medrxiv